Biggest News Aggregation in the World
📰 Cell Thyroid News

Cell Thyroid News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cell Thyroid. Real-time updates on events, politics, business and more.

FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc.

Press release content from Business Wire. The AP news staff was not involved in its creation. FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc. March 2, 2021 GMT WEST CHESTER, Pa.--(BUSINESS WIRE)--Mar 2, 2021-- Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced today the approval of an Investigational New Drug (IND) application by th...
United States Chris Pak Clinical Research Organization Newtown Molecular Targeting Technologies Inc National Institutes Of Health Drug Administration
Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science